Glaxosmithkline Consumer Private Limited, a active foreign private limited company, was established on 04 December 2014 in Patiala, Punjab, India. Engaging in consumer professional services within the professional, scientific and technical sector, it holds CIN: U24232PB2014FTC039082. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹125.00 Cr and a paid-up capital of ₹119.73 Cr.
It upholds a compliant status. Employing 536 professional, Its leadership includes Vikas Gupta (Nominee Director), Rupendra Yadav (Nominee Director), Vedika Kapoor (Additional Director). Past directors included Raj Kumar Khemani, Satish Ramchandra Dipali, Nilanjan Ghose. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Patiala Road Nabha, Patiala, Punjab, 147201.
U24232PB2014FTC039082
039082
04 December 2014
₹125.00 Cr
₹119.73 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Glaxosmithkline Consumer Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Gupta | Nominee Director | 30 Mar 2020 | Current |
| Rupendra Yadav | Nominee Director | 16 Jun 2021 | Current |
| Vedika Kapoor | Additional Director | 03 Mar 2025 | Current |
| Rixon Singla | Additional Director | 03 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 18 Nov 2022 | Past |
| Pramod Abcsdd | Additional Director | 23 May 2016 | Past |
| Pramod Abcsdd | Director | 24 Dec 2014 | Past |
| Pramod Abcsdd | Director | 24 Dec 2014 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 Mar 2020 | Past |
| Pramod Abcsdd | Whole-Time Director | 22 Feb 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glaxosmithkline Consumer Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.72% increase. The company also saw a slight improvement in profitability, with a 5.43% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Glaxosmithkline Consumer had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Glaxosmithkline Consumer has a workforce of 536 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Consumer, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Consumer's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Glaxosmithkline Consumer Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Glaxosmithkline Consumer Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was documented.
Vedika Kapoor was appointed as a Additional Director was appointed as a Additional Director on 03 Mar 2025 & has been associated with this company since 9 months 14 days . was recorded as a recent event.
Rixon Singla was appointed as a Additional Director was appointed as a Additional Director on 03 Mar 2025 & has been associated with this company since 9 months 14 days . was recorded as a recent event.
Progress on Meenu Rai was appointed as a Company Secretary was appointed as a Company Secretary on 16 Jan 2024 & has been associated with this company since 1 year 11 months . was documented.
Progress on Rupendra Yadav was appointed as a Nominee Director was appointed as a Nominee Director on 16 Jun 2021 & has been associated with this company since 4 years 6 months . was documented.
The CIN of Glaxosmithkline Consumer Private Limited is U24232PB2014FTC039082.
Glaxosmithkline Consumer Private Limited is headquartered at Patiala Road Nabha, Patiala, Punjab, 147201.
Glaxosmithkline Consumer Private Limited was incorporated on 04 December 2014.
The current directors of Glaxosmithkline Consumer Private Limited are
The primary industry of Glaxosmithkline Consumer Private Limited is Professional, Scientific And Technical.
Glaxosmithkline Consumer Private Limited is unlisted.
The authorized capital of Glaxosmithkline Consumer Private Limited is ₹125.00 Cr, and the paid-up capital is ₹119.73 Cr.
The compliance status of Glaxosmithkline Consumer Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX